Cleared Traditional

K993839 - ENA PROFILE ELISA TEST SYSTEM

K993839 is the FDA 510(k) clearance for ENA PROFILE ELISA TEST SYSTEM by Trinity Biotech USA. It is a Class 2 Immunology device (product code LLL) cleared through the Traditional 510(k) pathway after a 61-day FDA review.

K993839 · Trinity Biotech USA · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2000
Decision
61d
Days
Class 2
Risk

K993839 is an FDA 510(k) clearance for the ENA PROFILE ELISA TEST SYSTEM. Classified as Extractable Antinuclear Antibody, Antigen And Control (product code LLL), Class II - Special Controls.

Submitted by Trinity Biotech USA (Jamestown, US). The FDA issued a Cleared decision on January 12, 2000 after a review of 61 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5100 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Trinity Biotech USA devices

Submission Details

510(k) Number K993839 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 12, 1999
Decision Date January 12, 2000
Days to Decision 61 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
43d faster than avg
Panel avg: 104d · This submission: 61d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLL Extractable Antinuclear Antibody, Antigen And Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - LLL Extractable Antinuclear Antibody, Antigen And Control

All 117
Devices cleared under the same product code (LLL) and FDA review panel - the closest regulatory comparables to K993839.
ENA EIA KIT RANGE
K010146 · The Binding Site, Ltd. · Mar 2001
ENA EIA KIT
K010147 · The Binding Site, Ltd. · Mar 2001
ENA SCREEN EIA KIT
K010148 · The Binding Site, Ltd. · Feb 2001
QUANTA LITE ANA ELISA
K991657 · Inova Diagnostics, Inc. · Jun 1999
LIQUICHEK ENA CONTROL, EIA SCREEN, MODEL NO. 206
K984462 · Bio-Rad · Dec 1998
THE APTUS (AUTOMATED) APPLICATON OF THE ENA SCREEN ELISA TEST SYSTEM. AN ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) FOR S
K983376 · Zeus Scientific, Inc. · Nov 1998